PIRFENIDONE
Manner of administration:Oral
Restriction
Indication: Idiopathic pulmonary fibrosis
Treatment phase: Initial treatment 1 - new patient
Restriction
Indication: Idiopathic pulmonary fibrosis
Treatment phase: Initial treatment 2 - change or recommencement of treatment
Restriction
Indication: Idiopathic pulmonary fibrosis
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 3 | Max qty units: 270 | # of repeats: 5 | DPMQ: $426.75 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||